Interest in non-invasive brain-based therapies continues to grow across psychiatry. A recent study on neurofeedback learning in ADHD, highlighted within ongoing advances in interventional psychiatry research, suggests that the relationship between brain training and symptom improvement may be more complex than previously assumed.
Neurofeedback has been studied for decades as a way to help patients regulate their own brain activity. By providing real-time feedback from EEG signals, the technique aims to train individuals to modify patterns of neural activity associated with attention, impulse control, and cognitive performance.
However, new findings indicate that even when children successfully learn to regulate brainwave activity during neurofeedback training, clinical symptom improvement may not necessarily follow.
How Neurofeedback Is Currently Used in ADHD Care
Neurofeedback is often presented as a promising non-pharmacological intervention for attention-deficit/hyperactivity disorder. The therapy typically involves repeated training sessions in which patients observe visual or auditory feedback tied to their brainwave patterns.
One widely studied target is the theta-beta ratio, an EEG marker associated with attention and arousal. Many neurofeedback protocols attempt to reduce excessive theta activity while increasing beta activity, theoretically improving attentional control.
While some randomized trials have reported improvements in ADHD symptoms, the broader evidence base has remained mixed. Researchers have debated whether clinical benefits arise directly from learned brain regulation or from non-specific factors such as motivation, therapeutic engagement, or structured behavioral training environments.
The new study attempts to address this long-standing question.
Studying Neurofeedback Learning in ADHD Over Time
Researchers conducted a 25-month longitudinal randomized controlled trial involving 100 children between the ages of seven and ten diagnosed with ADHD.
Participants completed a structured theta-beta neurofeedback training protocol while researchers closely tracked changes in EEG patterns across sessions. Rather than analyzing results only at the group level, the investigators used clustering techniques to examine how individuals learned over time.
This approach allowed the research team to examine learning curves within and between sessions, capturing subtle patterns that traditional analyses often miss.
The goal was to determine whether successful neurofeedback learning directly predicted improvements in ADHD symptoms.
Key Findings Reveal a Complex Relationship
The results revealed a striking pattern. Most participants were able to learn the targeted brain regulation task and successfully adjust their theta-beta ratio during training sessions.
Despite this learning success, symptom improvement did not consistently correlate with the degree of neurofeedback learning.
Instead, statistical modeling suggested that other factors were stronger predictors of clinical outcomes. These included levels of participant engagement, contextual elements of the training environment, and broader behavioral influences.
In other words, the ability to control brain activity during training did not automatically translate into meaningful changes in ADHD symptoms.
Different Learning Pathways Across Children
The study also revealed that neurofeedback learning is highly individualized.
Rather than following a single trajectory, participants showed a wide range of learning patterns. Some children improved steadily across sessions, while others demonstrated fluctuating or delayed learning curves.
These patterns suggest that neurofeedback training may engage multiple underlying mechanisms.
For some individuals, learning appears to resemble operant conditioning, in which reinforcement gradually shapes brain activity patterns. For others, the process may resemble skill acquisition, requiring cognitive strategies and active engagement.
This heterogeneity challenges the assumption that neurofeedback operates through a single unified mechanism.
Why the Study Matters for Neurofeedback Research
The findings carry important implications for both research and clinical practice.
First, they suggest that neurofeedback success should not be defined solely by EEG learning metrics. Brain regulation performance during training may represent only one component of a more complex therapeutic process.
Second, the results highlight the importance of individual variability. Standardized neurofeedback protocols may overlook meaningful differences in how patients engage with and benefit from the training.
Future studies may need to incorporate personalized approaches that account for learning profiles, engagement levels, and broader behavioral contexts.
Finally, the research emphasizes the need for better mechanistic models explaining how neurofeedback interacts with cognitive and behavioral processes.
What This Means for the Future of ADHD Neurofeedback
Neurofeedback remains a promising tool within the expanding landscape of non-invasive psychiatric treatments. Its ability to directly target brain activity continues to attract interest from clinicians, researchers, and families seeking alternatives to medication.
At the same time, this new research highlights an important lesson for the field.
Brain training alone may not fully explain clinical improvement. Instead, neurofeedback outcomes may emerge from a combination of neural learning, behavioral engagement, and environmental factors.
Understanding how these elements interact will be essential as neurofeedback continues to evolve within the broader framework of precision psychiatry.
As research progresses, identifying which patients benefit most from neurofeedback learning in ADHD could help guide more individualized and effective treatment strategies.
Citations
Kuznetsova E, de Beus R, Arnold LE, et al.
Learning in Neurofeedback is Heterogenous and Does Not Guarantee ADHD Symptom Improvement.
Applied Psychophysiology and Biofeedback.
https://doi.org/10.1007/s10484-026-09774-w
Arnold LE, Arns M, Barterian J, et al.
Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for ADHD With 13-Month Follow-up.
Journal of the American Academy of Child & Adolescent Psychiatry.
https://doi.org/10.1016/j.jaac.2020.07.906
Explore more research at
https://www.interventionalpsychiatry.org/